The ERA-EDTA Registry Annual Report 2018: a summary
Status PubMed-not-MEDLINE Language English Country Great Britain, England Media electronic-ecollection
Document type Journal Article
PubMed
33564410
PubMed Central
PMC7857839
DOI
10.1093/ckj/sfaa271
PII: sfaa271
Knihovny.cz E-resources
- Keywords
- dialysis, epidemiology, kidney failure, kidney transplantation, survival analysis,
- Publication type
- Journal Article MeSH
BACKGROUND: The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries. METHODS: Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated. RESULTS: In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were ≥65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009-13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.
Abdominal Center Nephrology University of Helsinki and Helsinki University Hospital Helsinki Finland
Chronic Dialysis Russia and CIS Medical Department Company Baxter AO Moscow Russia
CIBER Epidemiología y Salud Pública Madrid Spain
Clinic of Nephrology Clinical Center University of Sarajevo Sarajevo Bosnia Herzegovina
Clinical Center of Montenegro Clinic for Nephrology Podgorica Montenegro
Complejo Hospitalario de Navarra Pamplona Navarra Spain
Cyprus Renal Registry Nicosia Cyprus
Department of Aragon Health General Direction of Health Care Zaragoza Spain
Department of Internal Medicine Riga Stradins University Riga Latvia
Department of Internal Medicine Swedish Renal Registry Jonkoping Regional Hospital Jonkoping Sweden
Department of Internal Medicine University of Tartu Tartu University Hospital Tartu Estonia
Department of Medicine General University Hospital Prague Strahov Czech Republic
Department of Medicine Holbaek Hospital Holbaek Denmark
Department of Nephrology American Medical Center Nicosia Cyprus
Department of Nephrology Hospital University Virgen del Rocio Seville Spain
Department of Nephrology Istanbul University Cerrahpasa Cerrahpasa Medical Faculty Istanbul Turkey
Department of Nephrology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania
Department of Nephrology Riga Stradins clinical University Hospital Riga Latvia
Department of Preventive Medicine and Public Health Universitat de Valencia Valencia Spain
Department of Transplantation Oslo University Hospital Rikshospitalet Oslo Norway
Dialysis clinic Alexandrovska University Hospital Sofia Medical University Sofia Bulgaria
Division of Nephrology Ambroise Paré University Hospital Boulogne Billancourt France
Division of Nephrology Landspitali The National University Hospital of Iceland Reykjavik Iceland
Division of Population Health and Genomics University of Dundee Dundee UK
Dutch Registry RENINE Nefrovsie Utrecht The Netherlands
Faculty of Medicine School of Health Sciences University of Iceland Reykjavik Iceland
Faculty of Medicine University Ss Cyril and Methodius Skopje Skopje N Macedonia
Finnish Registry for Kidney Diseases Helsinki Finland
Institute of Nephrology City Hospital Waid and Triemli Zurich Switzerland
Israel Renal Registry Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel
Latvian Nephrology Association Riga Latvia
Lithuanian Nephrology Dialysis and Transplantation Association Kaunas Lithuania
Minsk Scientific and Practical Center of Surgery Transplantation and Hematology Minsk Belarus
Portuguese Renal Registry Coimbra Portugal
REIN Registry Agence de la Biomédecine Saint Denis La Plaine France
Renal Replacement Registry Russian Dialysis Society Moscow Russia
RERCA Public Health Directorate Asturias Spain
Scottish Renal Registry Meridian Court Information Services Division Scotland Glasgow UK
Service of Nephrology UHC Mother Teresa Tirana Albania
Spanish Consortium for Research on Epidemiology and Public Health Madrid Spain
State Institute of Nephrology National Academy of Medical Sciences of Ukraine Kiev Ukraine
Unidad de Información de Pacientes Renales UNIPAR Basque Country Spain
University Hospital of Nephrology Skopje N Macedonia
Valencia Region Renal Registry Direccio General de Salut Publica i Adiccions Valencia Spain
See more in PubMed
ERA-EDTA Registry. ERA-EDTA registry annual report 2018. Amsterdam UMC, Department of Medical Informatics, Amsterdam, the Netherlands: Amsterdam UMC, 2020
Kramer A, Boenink R, Noordzij M. et al. The ERA-EDTA registry annual report 2017: a summary. Clin Kidney J 2020; 13: 693–709 PubMed PMC
The ERA Registry Annual Report 2019: summary and age comparisons
Antibody-mediated rejection of renal allografts: diagnostic pitfalls and challenges